应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
RDC 罗文
退市 12-09 16:00:00 EST
10.93
+0.00
0.00%
最高
10.93
最低
10.93
成交量
0.00
今开
10.93
昨收
10.93
日振幅
0.00%
总市值
13.91亿
流通市值
11.58亿
总股本
1.27亿
成交额
0.00
换手率
0.00%
流通股本
1.06亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
观察|上海浦东:营商服务“最后一公里”,如何成就“最优一公里”?
澎湃新闻 · 09-09
观察|上海浦东:营商服务“最后一公里”,如何成就“最优一公里”?
据国药控股消息近日经上海市药品监督管理局批准国药控股所属分销中心获得《放射性药品经营许可证》国药控股正式进入放射性核素偶
智通财经 · 09-08
据国药控股消息近日经上海市药品监督管理局批准国药控股所属分销中心获得《放射性药品经营许可证》国药控股正式进入放射性核素偶
【券商聚焦】中信证券:预计未来中国前列腺癌RDC诊疗市场将超100亿元
金吾财讯 · 08-29
【券商聚焦】中信证券:预计未来中国前列腺癌RDC诊疗市场将超100亿元
中信证券研报表示创新核药RDC有望解决目前前列腺癌诊疗过程中检测负担大、疗效有限等未被满足临床需求改变前列腺癌诊疗范式实
智通财经 · 08-29
中信证券研报表示创新核药RDC有望解决目前前列腺癌诊疗过程中检测负担大、疗效有限等未被满足临床需求改变前列腺癌诊疗范式实
思路迪医药股份(01244.HK):新型放射性核素偶联药物3D1015首次人体给药成功
智通财经 · 08-28
思路迪医药股份(01244.HK):新型放射性核素偶联药物3D1015首次人体给药成功
思路迪医药股份:新型放射性核素偶联药物3D1015首次人体给药成功
格隆汇资讯 · 08-28
思路迪医药股份:新型放射性核素偶联药物3D1015首次人体给药成功
中信证券研报表示创新核药RDC有望解决目前前列腺癌诊疗过程中检测负担大、疗效有限等未被满足临床需求改变前列腺癌诊疗范式实
智通财经 · 08-24
中信证券研报表示创新核药RDC有望解决目前前列腺癌诊疗过程中检测负担大、疗效有限等未被满足临床需求改变前列腺癌诊疗范式实
中期业绩稳健增长 远大医药股价涨超4% 核药营收翻倍稳居领军企业地位
智通财经网 · 08-20
中期业绩稳健增长 远大医药股价涨超4% 核药营收翻倍稳居领军企业地位
报名开启!艳阳三月,去益阳南县跑半马赏罗文花海
华声在线 · 02-14
报名开启!艳阳三月,去益阳南县跑半马赏罗文花海
由前花旗集团高管创立的初创公司Receipts Depositary将推出XRP支持的证券
金色财经 · 02-08
由前花旗集团高管创立的初创公司Receipts Depositary将推出XRP支持的证券
罗文看望慰问春节期间一线值班人员
财经自媒体 · 01-28
罗文看望慰问春节期间一线值班人员
【券商聚焦】国元国际维持远大医药(00512)“买入”评级 料RDC创新产品推动公司业绩继续上升
金吾财讯 · 2024-12-27
【券商聚焦】国元国际维持远大医药(00512)“买入”评级 料RDC创新产品推动公司业绩继续上升
远大医药全球创新RDC药物TLX250-CDx完成国内III期临床首例患者入组给药
经济参考网 · 2024-11-28
远大医药全球创新RDC药物TLX250-CDx完成国内III期临床首例患者入组给药
下任美财长持续"难产",罗文成特朗普财长热门人选
国际金融报 · 2024-11-21
下任美财长持续"难产",罗文成特朗普财长热门人选
情况有变!这位亿万富翁成为美国财长“头号竞争者”
金十数据 · 2024-11-21
情况有变!这位亿万富翁成为美国财长“头号竞争者”
加载更多
公司概况
公司名称:
罗文
所属市场:
NYSE
上市日期:
--
主营业务:
罗文公司于2012年5月4日在英格兰和威尔士成立,是Rowan Companies, Inc. (RCI)的发行继承人,公司是提供国际及国内离岸钻井承包服务的主要供应商。Rowan于1947年成立于特拉华州并且继承了Rowan Drilling Company, Inc.的钻井承包业务。公司利用机群31自升式海上移动式钻井平台(自升式钻井平台)提供离岸合同钻井服务。公司的主要重点是高规格的自升式钻井平台、客户使用的探测和开发钻井、在一些地区的修井操作。
发行价格:
--
{"stockData":{"symbol":"RDC","market":"US","secType":"STK","nameCN":"罗文","latestPrice":10.93,"timestamp":1575925200000,"preClose":10.93,"halted":4,"volume":0,"delay":0,"floatShares":105959169,"shares":127294643,"eps":-2.74,"marketStatus":"退市","change":0,"latestTime":"12-09 16:00:00 EST","open":10.93,"high":10.93,"low":10.93,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.74,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765184400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":-73684800000,"exchange":"NYSE","adjPreClose":10.93,"volumeRatio":0},"requestUrl":"/m/hq/s/RDC","defaultTab":"news","newsList":[{"id":"2566165802","title":"观察|上海浦东:营商服务“最后一公里”,如何成就“最优一公里”?","url":"https://stock-news.laohu8.com/highlight/detail?id=2566165802","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566165802?lang=zh_cn&edition=full","pubTime":"2025-09-09 06:56","pubTimestamp":1757372160,"startTime":"0","endTime":"0","summary":"上海的营商环境改革已从市级的“宏观政策赋能”阶段,进入到街镇的“微观服务决胜”阶段。浦东新区作为营商环境综合示范区,在区营商环境8.0版行动方案中提出,聚焦“打通最后一公里”,着力赋能基层营商环境建设。“优化营商环境,要形成政、企和社区共生的生态,营商环境最后一公里,才可能成为‘最优一公里’。”比如,优化涉企行政检查也是今年上海市营商环境8.0版行动方案的重点任务之一。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2025-09-09/doc-infpvyaw0691155.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-09-09/doc-infpvyaw0691155.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["RDC"],"gpt_icon":0},{"id":"2565018905","title":"据国药控股消息近日经上海市药品监督管理局批准国药控股所属分销中心获得《放射性药品经营许可证》国药控股正式进入放射性核素偶","url":"https://stock-news.laohu8.com/highlight/detail?id=2565018905","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565018905?lang=zh_cn&edition=full","pubTime":"2025-09-08 16:21","pubTimestamp":1757319712,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0640798160.USD","BK1197","LU0965088593.USD","LU1115378108.SGD","NIYmain","JMImain","01099","JNImain","NKmain","RDC","BK1515","NK225MCmain","BK1500"],"gpt_icon":0},{"id":"2563109559","title":"【券商聚焦】中信证券:预计未来中国前列腺癌RDC诊疗市场将超100亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2563109559","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563109559?lang=zh_cn&edition=full","pubTime":"2025-08-29 08:53","pubTimestamp":1756428810,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信证券表示,创新核药RDC有望解决目前前列腺癌诊疗过程中检测负担大、疗效有限等未被满足临床需求,改变前列腺癌诊疗范式,实现诊疗一体化,提高患者依从性和生存期。目前中国尚无任何RDC上市,市场呈现蓝海状态,海外前列腺癌RDC诊疗产品在2021年上市,2024年市场已接近30亿美元,充分验证了其巨大的商业价值。该机构认为中国有望复刻海外前列腺癌RDC诊疗市场发展路径,预计未来中国前列腺癌RDC诊疗市场将超100亿元,市场呈现高速增长状态。该机构认为该行业关键点为核素、配体分子形态、生产配送能力,建议关注在上述条件具有优势的公司。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/YzM1MzBiNWM5MmUxNDYxMGFiODk0MWI5MWJmNTU3YjMxMTA4MTkwNzI1ODY3.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YzM1MzBiNWM5MmUxNDYxMGFiODk0MWI5MWJmNTU3YjMxMTA4MTkwNzI1ODY3.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1965099","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1516","LU0405327148.USD","600030","LU1720050803.USD","LU1328615791.USD","LU1064130708.USD","LU1064131003.USD","LU1255011170.USD","RDC","LU2495084118.USD","LU1655091616.SGD","LU2289578879.USD","BK0012","LU2148510915.USD","BK1521","BK1564","LU0405327494.USD","BK0196","BK0183","LU1794554557.SGD","BK0276","LU1997245094.SGD","LU1997245177.USD","BK0188","06030","BK0028","BK1147","LU1997244956.HKD"],"gpt_icon":0},{"id":"2563009585","title":"中信证券研报表示创新核药RDC有望解决目前前列腺癌诊疗过程中检测负担大、疗效有限等未被满足临床需求改变前列腺癌诊疗范式实","url":"https://stock-news.laohu8.com/highlight/detail?id=2563009585","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563009585?lang=zh_cn&edition=full","pubTime":"2025-08-29 08:43","pubTimestamp":1756428217,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK0188","BK1521","LU1997245094.SGD","BK0012","RDC","BK0196","BK1564","LU0405327148.USD","600030","06030","LU1655091616.SGD","LU1328615791.USD","LU2289578879.USD","BK0183","LU1794554557.SGD","BK0276","LU1255011170.USD","LU1997244956.HKD","LU1064130708.USD","BK1147","LU2495084118.USD","LU1997245177.USD","BK1516","LU2148510915.USD","BK0028","LU0405327494.USD","LU1720050803.USD","LU1064131003.USD"],"gpt_icon":0},{"id":"2562082432","title":"思路迪医药股份(01244.HK):新型放射性核素偶联药物3D1015首次人体给药成功","url":"https://stock-news.laohu8.com/highlight/detail?id=2562082432","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562082432?lang=zh_cn&edition=full","pubTime":"2025-08-28 17:36","pubTimestamp":1756373778,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["RDC.AU","RDC","01244","BK1161"],"gpt_icon":0},{"id":"2562035551","title":"思路迪医药股份:新型放射性核素偶联药物3D1015首次人体给药成功","url":"https://stock-news.laohu8.com/highlight/detail?id=2562035551","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562035551?lang=zh_cn&edition=full","pubTime":"2025-08-28 17:24","pubTimestamp":1756373083,"startTime":"0","endTime":"0","summary":"格隆汇8月28日丨思路迪医药股份(01244.HK)公告,公司首款自主研发的放射性核素偶联药物(RDC)177Lu-PSMA-3D1015(\"3D1015\")已成功完成首例患者给药。本研究旨在评估3D1015用于PSMA阳性转移性去势抵抗性前列腺癌(mCRPC)患者的安全性与初步疗效。该研究人群精准聚焦于PSMA阳性转移性去势抵抗性前列腺癌(mCRPC)患者。研究将围绕3D1015的核心临床价值展开系统评估,重点包括药物的安全性及辐射剂量学评估,同时将深度收集药物在人体中的药代动力学特征、剂量探索数据,为后续注册临床试验的剂量确定与风险控制提供直接临床依据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508281724549766ec65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508281724549766ec65&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RDC"],"gpt_icon":0},{"id":"2561257602","title":"中信证券研报表示创新核药RDC有望解决目前前列腺癌诊疗过程中检测负担大、疗效有限等未被满足临床需求改变前列腺癌诊疗范式实","url":"https://stock-news.laohu8.com/highlight/detail?id=2561257602","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561257602?lang=zh_cn&edition=full","pubTime":"2025-08-24 16:27","pubTimestamp":1756024041,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["RDC","600030","BK1147","LU1794554557.SGD","LU2148510915.USD","LU1064131003.USD","LU1255011170.USD","LU1997245094.SGD","LU1064130708.USD","LU2495084118.USD","LU2289578879.USD","LU1997245177.USD","BK0183","LU1655091616.SGD","LU0405327148.USD","LU1720050803.USD","BK1564","BK0028","BK1521","BK0196","BK0276","LU1328615791.USD","BK0012","BK0188","06030","BK1516","LU1997244956.HKD","LU0405327494.USD"],"gpt_icon":0},{"id":"2561045569","title":"中期业绩稳健增长 远大医药股价涨超4% 核药营收翻倍稳居领军企业地位","url":"https://stock-news.laohu8.com/highlight/detail?id=2561045569","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561045569?lang=zh_cn&edition=full","pubTime":"2025-08-20 18:46","pubTimestamp":1755686770,"startTime":"0","endTime":"0","summary":"资本市场反响强烈,8月20日,公司股价以4.37%的涨幅最终报收9.31港元,或将开启远大医药本年度的新一轮的股价增长周期。上半年,远大医药创新及壁垒产品收入占比约51%,同比提升近15个百分点。在核药领域,远大医药是全球仅有的四家实现创新核药商业化的药企之一。目前,远大医药正在积极推进创新核药“Go Global”。今年上半年,公司成都温江核药研发及生产基地的投运标志着远大医药已实现了从实验室研发到工业化量产的战略性跨越。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250820184845a493d86c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250820184845a493d86c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RDC"],"gpt_icon":0},{"id":"2511663584","title":"报名开启!艳阳三月,去益阳南县跑半马赏罗文花海","url":"https://stock-news.laohu8.com/highlight/detail?id=2511663584","media":"华声在线","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511663584?lang=zh_cn&edition=full","pubTime":"2025-02-14 18:03","pubTimestamp":1739527380,"startTime":"0","endTime":"0","summary":"2月14日,记者获悉,目前赛事报名通道已开启,即日起至2025年3月8日,选手可通过相关平台参与报名。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-02-14/doc-inekmyre6718616.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["RDC"],"gpt_icon":0},{"id":"2509774779","title":"由前花旗集团高管创立的初创公司Receipts Depositary将推出XRP支持的证券","url":"https://stock-news.laohu8.com/highlight/detail?id=2509774779","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509774779?lang=zh_cn&edition=full","pubTime":"2025-02-08 05:58","pubTimestamp":1738965529,"startTime":"0","endTime":"0","summary":null,"market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.coindesk.com/markets/2025/02/07/startup-founded-by-citi-alumni-to-launch-xrp-backed-securities?_gl=1*1303ezt*_up*MQ..*_ga*MTA0MzQ0MDM0Mi4xNzM4Njg4MDIw*_ga_VM3STRYVN8*MTczODk0NTI0OS4yMS4xLjE3Mzg5NTYxOTQuMC4wLjEyMzM0MTU2Mjk.","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["LU1668664300.SGD","03439","XBTmain","BK4207","03046","BK1611","ETH","BTC","BK7016","03009","LU0477156953.USD","BK4588","RDC","09009","IBIT","09042","BK7094","DTC.AU","LU1267930227.SGD","BTCmain","RDC.AU","BTC.AU","161027","BTC.USD.CC","BTC.USD.HKCC","09046","ADR.AU","03042","03179","09008","LU0130517989.USD","LU0320765646.SGD","BK4504","09439","LU0648001328.SGD","LU1791807156.HKD","03008","LU0170899867.USD","IE00BSNM7G36.USD","LU2417539215.USD","83042","DTC","BK4534","ETH.USD.HKCC","09179","BK4190","SEC.AU","BK4594","MSTU"],"gpt_icon":0},{"id":"2506567854","title":"罗文看望慰问春节期间一线值班人员","url":"https://stock-news.laohu8.com/highlight/detail?id=2506567854","media":"财经自媒体","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506567854?lang=zh_cn&edition=full","pubTime":"2025-01-28 16:00","pubTimestamp":1738051200,"startTime":"0","endTime":"0","summary":"来源:市说新语1月28日除夕上午,市场监管总局党组书记、局长罗文到总局机关检查值守应急工作,电话连线地方市场监管部门,慰问一线值班人员,对节日值班工作提出明确要求。罗文强调,春节是中华民族最重要的传统节日之一,维护好春节期间市场秩序和安全稳定意义十分重大。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/xwzmt/2025-01-28/doc-inehpimz0094320.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["RDC"],"gpt_icon":0},{"id":"2494826134","title":"【券商聚焦】国元国际维持远大医药(00512)“买入”评级 料RDC创新产品推动公司业绩继续上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2494826134","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494826134?lang=zh_cn&edition=full","pubTime":"2024-12-27 13:31","pubTimestamp":1735277490,"startTime":"0","endTime":"0","summary":"公司秉持“自主研发+全球扩展”战略,目前国内已有四款RDC创新产品获批开展临床试验,3款处于临床研究III期。RDC市场空间广阔,将推动公司业绩继续上升,并有望提升估值,该行给予公司目标价格为8.28港元,对应2024年13.8倍PE,较现价有74.6%的上涨空间。维持‘买入’评级。","market":"sh","thumbnail":"https://static.szfiu.com/news/20241108/MDc2YjQxZmY4Y2VkNWEzNDU4MmJiNGExMDgxOTA3MjUwMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MDc2YjQxZmY4Y2VkNWEzNDU4MmJiNGExMDgxOTA3MjUwMzc=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1950330","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RDC","00512"],"gpt_icon":0},{"id":"2486391441","title":"远大医药全球创新RDC药物TLX250-CDx完成国内III期临床首例患者入组给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2486391441","media":"经济参考网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486391441?lang=zh_cn&edition=full","pubTime":"2024-11-28 18:21","pubTimestamp":1732789267,"startTime":"0","endTime":"0","summary":"11月28日,远大医药公告称,其用于诊断肾透明细胞癌(ccRCC)的全球创新放射性核素偶联药物(RDC)TLX250-CDx已完成国内III期临床研究的首例患者入组给药。据介绍,TLX250-CDx(89Zr-TLX250)是一款全球创新的适用于ccRCC诊断的放射性核素偶联药物,其靶点为碳酸酐酶IX(CAIX),CAIX在ccRCC和其他许多癌种中过度表达。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411283253859877.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["III","RDC","00512","BK4134","BK1191"],"gpt_icon":0},{"id":"2485446289","title":"下任美财长持续\"难产\",罗文成特朗普财长热门人选","url":"https://stock-news.laohu8.com/highlight/detail?id=2485446289","media":"国际金融报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485446289?lang=zh_cn&edition=full","pubTime":"2024-11-21 18:37","pubTimestamp":1732185420,"startTime":"0","endTime":"0","summary":"据报道,私募股权大亨马克·罗文 已成为特朗普新一届政府财政部长职位的热门人选。罗文现任阿波罗全球管理公司负责人,在特朗普第一届政府期间曾为疫情时期的金融市场紧急对策提供建议,而其所在的阿波罗公司目前管理资产超过7000亿美元。其中,预测机构将沃什列为最可能当选的人选,而贝森特排名第二,罗文和哈格蒂则紧随其后。即便贝森特未能当选财政部长,他仍有望出任国家经济委员会主席。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2024-11-21/doc-incwvpzk1347920.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-11-21/doc-incwvpzk1347920.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["RDC"],"gpt_icon":0},{"id":"2484111720","title":"情况有变!这位亿万富翁成为美国财长“头号竞争者”","url":"https://stock-news.laohu8.com/highlight/detail?id=2484111720","media":"金十数据","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484111720?lang=zh_cn&edition=full","pubTime":"2024-11-21 09:58","pubTimestamp":1732154293,"startTime":"0","endTime":"0","summary":"预测网站显示前美联储理事沃什可能会在这场“财长之争”中获胜,一些知情人士则透露称,这位资管巨头CEO才是“头号竞争者”……","market":"hk","thumbnail":"https://static.tigerbbs.com/c4e15bc5ec6e1753390253b04c7adb1f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c4e15bc5ec6e1753390253b04c7adb1f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://xnews.jin10.com/webapp/details.html?id=153884&type=news&data_type=0","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"xnew_highlight","symbols":["LU1323610961.USD","IE00B3S45H60.SGD","IE0002270589.USD","BK4184","IE00B19Z3581.USD","IE00B19Z3B42.SGD","RDC","BIDU","IE00B775SV38.USD","LU0006061336.USD","LU0106831901.USD","RDC.AU","BK4135","LU1668664300.SGD","LU1791807156.HKD","APO"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.rowan.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0034},{"period":"1month","weight":0.012},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1445},{"period":"1year","weight":0.1303},{"period":"ytd","weight":0.17}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"罗文公司于2012年5月4日在英格兰和威尔士成立,是Rowan Companies, Inc. (RCI)的发行继承人,公司是提供国际及国内离岸钻井承包服务的主要供应商。Rowan于1947年成立于特拉华州并且继承了Rowan Drilling Company, Inc.的钻井承包业务。公司利用机群31自升式海上移动式钻井平台(自升式钻井平台)提供离岸合同钻井服务。公司的主要重点是高规格的自升式钻井平台、客户使用的探测和开发钻井、在一些地区的修井操作。","exchange":"NYSE","name":"罗文","nameEN":"Rowan Companies PLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"罗文(RDC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供罗文(RDC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"罗文,RDC,罗文股票,罗文股票老虎,罗文股票老虎国际,罗文行情,罗文股票行情,罗文股价,罗文股市,罗文股票价格,罗文股票交易,罗文股票购买,罗文股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"罗文(RDC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供罗文(RDC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}